These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2217958)

  • 21. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.
    Nicknam MH; Mahmoudi M; Amirzargar AA; Ganjalikhani Hakemi M; Khosravi F; Jamshidi AR; Amirkhani A; Ansaripour B; Pourpak Z; Moin M; Nikbin B
    Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):19-24. PubMed ID: 18322308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia.
    Cascino I; Paladini F; Belfiore F; Cauli A; Angelini C; Fiorillo MT; Mathieu A; Sorrentino R
    Arthritis Rheum; 2007 Aug; 56(8):2640-51. PubMed ID: 17665395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of ankylosing spondylitis and radiological abnormalities of the sacroiliac joints in HLA-B27 positive individuals.
    Dawkins RL; Owen ET; Cheah PS; Christiansen FT; Calin AA; Gofton JP
    J Rheumatol; 1981; 8(6):1025-6. PubMed ID: 6977030
    [No Abstract]   [Full Text] [Related]  

  • 25. [Risk of developing ankylosing spondylitis in "healthy" persons positive for HLA-B27 antigen].
    Chappel R; Muylle L; Mortier G; Peetermans M; Brusselaers H
    Acta Rhumatol; 1979; 3(4):319-28. PubMed ID: 11496382
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic aspects of the spondyloarthropathies.
    Woodrow JC
    Clin Rheum Dis; 1985 Apr; 11(1):1-24. PubMed ID: 2581731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical application of the HLA-B27 test in rheumatic diseases. A current perspective.
    Khan MA
    Arch Intern Med; 1980 Feb; 140(2):177-80. PubMed ID: 6986127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free HLA class I heavy chain-carrying monocytes--a potential role in the pathogenesis of spondyloarthropathies.
    Tsai WC; Chen CJ; Yen JH; Ou TT; Tsai JJ; Liu CS; Liu HW
    J Rheumatol; 2002 May; 29(5):966-72. PubMed ID: 12022359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of HLA-B27 antigen with monoclonal antibodies.
    Engleman EG; Calin A; Grumet FC
    J Rheumatol Suppl; 1983 Nov; 10():59-61. PubMed ID: 6420568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABO blood group and secretor status in the spondyloarthropathies.
    Shinebaum R
    FEMS Microbiol Immunol; 1989 Jun; 1(6-7):389-95. PubMed ID: 2698732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, epidemiologic, and therapeutic aspects of ankylosing spondylitis.
    Gran JT; Husby G
    Curr Opin Rheumatol; 1998 Jul; 10(4):292-8. PubMed ID: 9725089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiopathogenesis and biochemical and immunologic evaluation of spondyloarthropathies.
    Scofield RH
    Curr Opin Rheumatol; 1996 Jul; 8(4):309-15. PubMed ID: 8864581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Juvenile spondyloarthropathies.
    Pepmueller PH; Moore TL
    Curr Opin Rheumatol; 2000 Jul; 12(4):269-73. PubMed ID: 10910178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and epidemiologic aspects of ankylosing spondylitis and spondyloarthropathies.
    van der Linden S; van der Heijde DM
    Curr Opin Rheumatol; 1996 Jul; 8(4):269-74. PubMed ID: 8864577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphadenopathy in an oriental with ankylosing spondylitis.
    Liou LB; Chen TC
    Clin Rheumatol; 1998; 17(5):412-5. PubMed ID: 9805192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spondylitic changes in long-finned pilot whales (Globicephala melas) stranded on Cape Cod, Massachusetts, USA, between 1982 and 2000.
    Sweeny MM; Price JM; Jones GS; French TW; Early GA; Moore MJ
    J Wildl Dis; 2005 Oct; 41(4):717-27. PubMed ID: 16456160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of environmental exposures and ankylosing spondylitis and spinal mobility: US NHAENS, 2009-2010.
    Shiue I
    Int J Environ Health Res; 2015; 25(3):322-9. PubMed ID: 25103950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies.
    Shinebaum R; Blackwell CC; Forster PJ; Hurst NP; Weir DM; Nuki G
    Br Med J (Clin Res Ed); 1987 Jan; 294(6566):208-10. PubMed ID: 3101813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The changing epidemiology of rheumatic diseases: should ankylosing spondylitis now be included?
    Will RK; Amor B; Calin A
    Br J Rheumatol; 1990 Aug; 29(4):299-300. PubMed ID: 2379047
    [No Abstract]   [Full Text] [Related]  

  • 40. [Factors determining the prognosis of rheumatic pelvi-spondylitis].
    Franchimont P; Focan-Henrard D; Heynen G
    Rev Med Liege; 1977 Mar; 32(6):165-8. PubMed ID: 854670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.